BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

Dendritic cell (DC) vaccines show promising effects in cancer immunotherapy. However, their efficacy is affected by a number of factors, including (1) the quality of the DC vaccine and (2) tumor immune evasion. The recently characterized BDCA1+CD14+ immunosuppressive cells combine both aspects; thei...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ee, Thomas J., Van Acker, Heleen H., van Oorschot, Tom G., Van Tendeloo, Viggo F., Smits, Evelien L., Bakdash, Ghaith, Schreibelt, Gerty, de Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161086/
https://www.ncbi.nlm.nih.gov/pubmed/30235890
http://dx.doi.org/10.3390/vaccines6030065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161086/
https://www.ncbi.nlm.nih.gov/pubmed/30235890
http://dx.doi.org/10.3390/vaccines6030065

Ejemplares similares